T cell receptor beta variable 11-2 (TRBV11-2)

T cell receptor beta variable 11-2 (TRBV11-2) is a protein subunit encoded by the *TRBV11-2* gene, forming the variable region of the beta chain in alpha-beta T cell receptors. TCRs are heterodimeric membrane-bound receptors on T lymphocytes that recognize antigenic peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. The variable beta chain region, contributed by TRBV11-2, is generated by V(D)J recombination in the thymus and is essential for antigen specificity and adaptive immune repertoire diversity. TRBV11-2 and its protein product play a critical role in T cell activation, signaling through CD3 complexes, and initiation of immune responses. Notably, TRBV11-2 has been implicated in abnormal clonal expansions in the context of certain diseases, such as MIS-C associated with SARS-CoV-2, possibly due to superantigen-like engagement. The protein is part of the immunoglobulin superfamily and contributes to the formation of complementarity-determining regions essential for peptide-MHC recognition. The TCR beta chain, including TRBV11-2 variations, is not known to be the direct target of marketed drugs but is central to T cell-targeted immunotherapies and is under research for disease biomarkers and selective immune modulation.

Other names

TRBV11-2TCRBV21S3A2N2TTRBV112TCRBV11S2V segment translation productVβ21.3

TCR engagement with peptide-MHC on antigen-presenting cells initiates signal transduction via CD3 complex and downstream kinases (e.g., LCK, ZAP70), leading to T cell activation, cytokine production, and clonal expansion. For drugs that interfere with TCRs, mechanisms may include blocking antigen recognition, modulating T cell responses, or redirecting T cells (as in cancer immunotherapy).